Lucintel Forecasts The Chikungunya Vaccine Market In United States To Reach $1 Billion By 2031

By Author: Lucintel LLC
Total Articles: 7912
Comment this article

According to a market report by Lucintel, the future of the chikungunya vaccine market in United States looks promising with opportunities in the hospital pharmacy and retail pharmacy markets. The chikungunya vaccine market in United States is expected to reach an estimated $1 billion by 2031 with a CAGR of 9.7% from 2025 to 2031. The chikungunya vaccine market in United States is also forecasted to witness strong growth over the forecast period. The major drivers for this market are rising awareness of infections transmitted by mosquitoes, expanding government programs for chikungunya prevention and control, and increasing chikungunya fever prevalence.
A more than 150-page report to understand trends, opportunity and forecast in chikungunya vaccine market in United States to 2031 by type (live-attenuated virus vaccines, inactivated viral vaccines, chimeric-alphavirus candidates, recombinant viral vaccines, and others), age group (paediatric, adult, and geriatric), and end use (hospital pharmacies, retail pharmacies, and others).
Download sample by clicking on chikungunya vaccine market in United States.
Lucintel ...
... forecasts that, within the type category, live-attenuated is expected to witness the highest growth over the forecast period.
Within the end use category, hospital pharmacies are expected to witness a higher growth.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Chikungunya Vaccine Market in Australia
Chikungunya Vaccine Market in Brazil
Chikungunya Vaccine Market in Canada
Chikungunya Vaccine Market in Mexico
Chikungunya Vaccine Market in Saudi Arabia
Chikungunya Vaccine Market in South Africa